The foundation of surgical decision-making has always been the risk-to-benefit ratio. Traditionally, the risks of complications and death, predicted by comorbid conditions, have been balanced against the benefits of disease management; that is, relief of symptoms or prevention of disease-related complications. Increasingly, patient preference and quality-of-life outcomes are entering into the decision-making process even at the price of modest increases in risk. In addition, the role of the surgeon as a predictor of outcomes has come under close scrutiny and has been demonstrated as having an effect on a number of important surgical outcomes. In the future, our methods for analyzing and reporting surgical outcomes will have to accommodate new predictors.
Perhaps one of the most defining changes in the specialty treatment of lower gastrointestinal diseases was the introduction of the ileal pouch-anal anastomosis (IPAA) for chronic ulcerative colitis and familial adenomatous polyposis. For the first time patients had the option of maintaining intestinal continuity while still being cured of their colonic disease. Patient preference strongly motivated the advancement of this new procedure. The introduction and development of minimally invasive or laparoscopic colorectal procedures was also driven by patient preference; further, it crystallized the concept of the learning curve. The impact of case volume experience or variables such as duration of surgery and rates of conversion to open surgery were clearly measurable and reportable.
These new procedures have changed the way we assess surgical outcomes to the point, in fact, that we are now scrutinizing established procedures in a manner similar to how we examine new procedures. As we have seen the effects of experience and expertise on new procedures, we have also realized the potential for this to influence results for procedures already considered standard and essential to our practice. The best example of this is the reinvention of rectal cancer surgery as total mesorectal excision or TME. In the
INTRODUCTION
For the time in which we live, the concept of change seems the only constant. This is particularly true for the manner and method for predicting surgical outcomes. Historically, patient comorbidities and disease severity variables were the primary factors considered for predicting surgical outcomes (Table 1) . Primary surgical outcomes included morbidity, mortality, and disease management. The general health of the patient and the severity and extent of the disease under surgical treatment were used to generate the risk-to-benefit ratio, the basis of surgical decision-making. The health of the patient predicted the risk of complications and death, and the extent of disease predicted both the need for surgery and the likelihood of a successful outcome; that is, relief of symptoms or prevention of disease-related complications. In the last two decades we have seen this equation expand to accommodate several new variables including the patient's preference, the influence of the learning curve and the surgeon's experience and expertise. Although such changes permeate all surgical disciplines, examples of how these new factors must be considered are readily available from the field of gastrointestinal surgery. present review, ileal pouch-anal anastomosis, laparoscopic colon and rectal surgery, and rectal cancer surgery will be discussed to provide a perspective on how these procedures influence the way we now make surgical decisions.
Ileal pouch-anal anastomosis
Although the first surgical procedure for ulcerative colitis was described in 1893, it was not until 1933 that the first ileoanal anastomosis was reported and not until 1978 that reservoir refinements seriously put this procedure within the grasp of patients. 1 The standard procedure, total proctocolectomy and Brooke ileostomy, was an excellent procedure by the old measures; that is, rates of complications and cure. Patients treated with proctocolectomy and ileostomy got excellent relief from the inflammatory disease or protection against cancer. Further, they experienced reasonable rates of morbidities and mortality. This procedure was acceptable to the treating physician but not desirable to the patients because of the necessity of a permanent stoma. In this circumstance, the old measures of outcomes were not sufficient. With time it became apparent that we had to incorporate new outcome measures including patient satisfaction and bowel function (i.e. quality of life).
Quality of life is not just a new measure; in fact, it is now a key measure of surgical outcomes. Quality of life as it pertains to the treatment of ulcerative colitis and familial adenomatous polyposis quickly overshadowed the previous measure of outcome; that is, rates of complications. We now witness on a routine basis how patients trade a modest degree of additional surgical risk for a modest degree of improved quality of life. Patients accept the risks inherent in the two surgical procedures of IPAA, risks that exceed those of the total proctocolectomy and ileostomy. They do so for the benefits of quality of life (avoiding a permanent stoma).
Several studies have demonstrated superior quality of life for patients following IPAA compared with the Brooke ileostomy or Kock pouch.
2 Indeed, many of the ongoing technical refinements of the procedure are focused on maximizing function. 3 Whether or not a mucosectomy and hand-sewn anastomosis should be performed to complete the resection of at-risk mucosa is debated against the preference for the double-stapled anastomosis, which theoretically offers improved continence. 4 Technical factors have clearly been implicated as predictors of surgical outcomes for the IPAA. Another predictive category is the preoperative functional status of the patient. To achieve the quality of life benefits patients must enter the procedure with a suitable functional status. The best results from the IPAA can be expected in younger patients and those with normal anal and pelvic floor musculature.
Another concept described with the analysis of the experience with IPAA regarding predictors of surgical outcomes has been the notion of surgeon experience. Using a large clinical database including the early experience with IPAA, from 1981 to 1985 and later experience from 1991 to 1994, it has been shown that procedure-specific complications were influenced by experience. When the IPAA was first introduced, rates of pelvic sepsis were as high as 7%, but with more experience with this new procedure, rates of pelvic sepsis decreased to 3%. 5 The concept of surgeon experience, as is true for IPAA, was described in the context of complications of the procedure. As will become evident, surgeon experience also predicts other important outcomes such as success at completing laparoscopic surgeries and even cancer outcomes such as rates of local recurrence for rectal cancer surgery.
Laparoscopic colon and rectal surgery
The introduction of minimally invasive surgery in the management of lower gastrointestinal diseases ushered in major changes in the way we measure and evaluate surgical outcomes. Not only are we now measuring morbidity, mortality, disease management and quality of life, we are also considering variables of feasibility such as rates of conversion, duration of surgery, and costs.
The possibility of laparoscopic colectomy followed soon after the demonstration of patient preference for laparoscopic cholecystectomy. As laparoscopic colectomy requires advanced laparoscopic skills, it was initially judged by whether it could be performed with acceptable rates of complications.The true laparoscopic colectomy with intracorporeal anastomosis was in fact associated with greater rates of complications and was abandoned in favor of the laparoscopic-assisted colectomy where a small incision was allowed for exteriorization, resection and anastomosis of the colon. 6 Once proven safe, other measures of feasibility such as rates of conversion and operative times became indicators of outcomes. For benign cases, the only real difference between open and laparoscopic colectomy was the manner of exposure for mobilization. Many reports demonstrated that the same extent of resection could be accomplished, so the focus shifted to the balance between resources consumed by the more complex surgical approach to resources preserved by reduced recovery times. The economic pressures of the times were not lost on this new procedure; if anything, they were magnified.
The fact that laparoscopic-assisted colectomy did not change the fundamental treatment of any disease meant that evaluating it required a new formula for outcomes assessment. Considered as patient friendly, minimally invasive surgery was accordingly judged by its impact on recovery. Length of stay, length of ileus, and duration of narcotic use were objective measures, perhaps more crucial was the patients' own perception of quality of life.Validated quality-of-life instruments were applied to monitor the impact of surgery on the patients' health. Instruments included symptom assessment using the McCorkle Symptom Distress Scale, functional status and utilities using the quality-of-life index, and a 0-100 ratings scale of general quality of life. 7 For benign diseases the risk-benefit equation was generally reduced to the notion of what is gained in the recovery phase versus what is lost in the operating room. Measures in the operating room include operating time, disposable equipment use (and costs), and rates of conversion. Predictors for these variables include patient factors such as obesity 8 and previous surgery and disease variables such as extent of inflammation and mass effect for Crohn's and diverticulitis. Interestingly enough, however, the most important variable predictive of successful outcome was the surgeon and their experience. The concept of the 'learning curve' actually materialized using objective measures in the era of laparoscopic surgery. Never before had it been so clearly demonstrated that the surgeon had an impact on outcomes and, further, that their ability to learn the procedure also had an impact. The effect of the learning curve showed great variability for both operative times (Table 2) 9-15 and rates of conversion (Table 3) . 9, 13, 14, 16, 17 For laparoscopic surgery and colon cancer the equation and the issues were quite different. Early case reports and then registry and series reports on trocar or wound recurrences following laparoscopic colectomy dampened enthusiasm for minimally invasive surgery in the setting of cancer. It was at least conceivable, based on this information, that tumor biology could be altered by exposure to the pneumoperitoneum. As gains in postoperative recovery are modest and short-lived, it seemed unreasonable to offer laparoscopic surgery in the setting of curable cancer without proof of efficacy and oncological equivalence. Accordingly, a number of large prospective trials were designed and initiated; for the USA trial, a complex equation using Q-TWiST 18 was proposed to provide balanced assessment of different health states. Q-TWiST or quality-adjusted time without symptoms of disease and toxicity of treatment incorporates five utility weighted health states including the perioperative period, adjuvant chemotherapy, time without symptoms and toxicity, late complications, and relapse (Fig. 1) . Results from the multicenter prospective randomized trial in the USA are not ready for reporting; no doubt a number of predictors will be identified at the conclusion of this study.
Rectal cancer surgery
The management of rectal cancer has become exceedingly complex with more surgical options to offer patients than ever before. As has been true in other fields, the emphasis has been focused on quality of life, specifically preservation of intestinal continuity and functional status. Toward this end, patients can be considered for sphincter-preserving options such as local excision, low anterior resection, or coloanal anastomosis as indicated. The key is to select the procedure most likely to produce good functional results without compromising oncological outcomes. Local excision has a very limited role in the management of rectal cancer. Although it minimally alters bowel function and can prevent the necessity for a stoma, it is associated with high rates of local pelvic relapse. For early T1 and T2 lesions, local recurrence rates are reported as high as 28%. 19 This is much higher than the 4% reported for standard resection. Current predictors for local failure following local excision of rectal cancer are depth of invasion and histological features such as lymphovascular invasion and degree of differentiation. 20, 21 Best results for local excision can be anticipated for patients who are frail, elderly, or have significant or life-limiting comorbid conditions and/or who have small T1 or early T2 lesions without lymphatic or venous invasion, with well-differentiated histology and completely excised.
Other sphincter-preserving options besides local excision include the low anterior resection and the coloanal anastomosis. Both of the latter operations are true oncological procedures in that they widely remove the primary tumor and primary draining lymph nodes. Tumor location relative to the sphincter determines the ability to achieve distal tumor-free margins of 1-2 cm as advised. 22 In some cases the application of preoperative radiation and chemotherapy may enhance the ability to achieve margins while preserving the sphincter complex. Predictors of functional results include preoperative status of the patient, specifically the degree of continence and frequency of bowel movements, and the exposure to radiation therapy. Technical factors include the amount of residual rectum in the case of the low anterior resection and the configuration and compliance of the colon and/or pouch. The colon 'J' pouch has been used to improve functional results for the first postoperative year.
Finally, a word must be said about the role of the surgeon as a predictor of rectal cancer surgery outcomes. Several countries in Europe and Canada have reported data substantiating the surgeon as a critical variable. A recent report from a United States community and cooperative group practice demonstrates the same. 23 Local recurrence rates can vary widely based solely on the experience and training of the surgeon. Further proof of this point is the fact that an educational program in Germany is credited with reducing local recurrence rates from 39% to 10%. 24 In the experience of Germany, attention to complete removal of the mesorectum is thought to have improved outcomes. As several technical factors probably contribute to optimal cancer results, surgeons are encouraged to follow the oncological principles detailed in a recent Journal of the National Cancer Institute Guidelines paper.
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CONCLUSION
Through specific examples of colon and rectal procedures, the evolution of surgical outcome measures and, accordingly, predictors of success can be demonstrated. Perhaps the most important changes in the measure of success are the current inclusion of the patient and their perspective in the equation as well as the inclusion of the surgeon and their level of experience and expertise. Concern over quality-of-life issues represents an important step forward. 
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